OBJECTIVE: Retinoids are crucial in the regulation of fundamental cellular processes including terminal differentiation of both normal and malignant myeloid progenitors. The aim of this study was to identify and characterize retinoic acid (RA) target genes. METHODS AND RESULTS: RTP801 is a recently cloned stress response gene that acts as a negative regulator of the mTOR pathway. Here we identified RTP801 as a novel early RA target gene in myeloid cells. RTP801 mRNA levels are induced in acute myeloid leukemia (AML) cell lines during RA-dependent differentiation and are differentially expressed during maturation of normal CD34(+) cells. The myeloid-specific, differentiation-related transcription factor C/EBPepsilon also induces RTP801 expression. Overexpression of RTP801 in the U937 leukemic cells leads to growth inhibition and apoptosis. Conversely, silencing of endogenous RTP801 by shRNA reduces RA-induced differentiation of the U937 cells. Downregulation of RTP801 also abrogates hypoxia-induced inhibition of mTOR in those cells. CONCLUSION: Taken together, our data suggest that RTP801 is an important RA-regulated gene involved in myeloid differentiation, which could represent a therapeutic target in leukemia.
OBJECTIVE:Retinoids are crucial in the regulation of fundamental cellular processes including terminal differentiation of both normal and malignant myeloid progenitors. The aim of this study was to identify and characterize retinoic acid (RA) target genes. METHODS AND RESULTS: RTP801 is a recently cloned stress response gene that acts as a negative regulator of the mTOR pathway. Here we identified RTP801 as a novel early RA target gene in myeloid cells. RTP801 mRNA levels are induced in acute myeloid leukemia (AML) cell lines during RA-dependent differentiation and are differentially expressed during maturation of normal CD34(+) cells. The myeloid-specific, differentiation-related transcription factor C/EBPepsilon also induces RTP801 expression. Overexpression of RTP801 in the U937 leukemic cells leads to growth inhibition and apoptosis. Conversely, silencing of endogenous RTP801 by shRNA reduces RA-induced differentiation of the U937 cells. Downregulation of RTP801 also abrogates hypoxia-induced inhibition of mTOR in those cells. CONCLUSION: Taken together, our data suggest that RTP801 is an important RA-regulated gene involved in myeloid differentiation, which could represent a therapeutic target in leukemia.
Authors: Rolf Schwarzer; Daniel Tondera; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann Journal: Oncogene Date: 2005-02-10 Impact factor: 9.867
Authors: Zhengqi Wang; Michael H Malone; Michael J Thomenius; Fei Zhong; Fang Xu; Clark W Distelhorst Journal: J Biol Chem Date: 2003-05-07 Impact factor: 5.157
Authors: James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin Journal: Genes Dev Date: 2004-11-15 Impact factor: 11.361
Authors: Peter Horak; Andrew R Crawford; Douangsone D Vadysirisack; Zachary M Nash; M Phillip DeYoung; Dennis Sgroi; Leif W Ellisen Journal: Proc Natl Acad Sci U S A Date: 2010-02-22 Impact factor: 11.205
Authors: Nicholas C Wolff; Silvia Vega-Rubin-de-Celis; Xian-Jin Xie; Diego H Castrillon; Wareef Kabbani; James Brugarolas Journal: Mol Cell Biol Date: 2011-03-07 Impact factor: 4.272
Authors: Timothy I Shaw; Anuj Srivastava; Wen-Chi Chou; Liang Liu; Ann Hawkinson; Travis C Glenn; Rick Adams; Tony Schountz Journal: PLoS One Date: 2012-11-15 Impact factor: 3.240
Authors: Toshinori Yoshida; Igor Mett; Anil K Bhunia; Joel Bowman; Mario Perez; Li Zhang; Aneta Gandjeva; Lijie Zhen; Ugonma Chukwueke; Tianzhi Mao; Amy Richter; Emile Brown; Hagit Ashush; Natalie Notkin; Anna Gelfand; Rajesh K Thimmulappa; Tirumalai Rangasamy; Thomas Sussan; Gregory Cosgrove; Majd Mouded; Steven D Shapiro; Irina Petrache; Shyam Biswal; Elena Feinstein; Rubin M Tuder Journal: Nat Med Date: 2010-05-16 Impact factor: 53.440